|
1) Parkin MTJE, Boffetta P, Samet J, et al. Lung cancer epidemiology and etiology. In: Travis WD, Brambilla E, Muller-Hermelink HK, et al editors. World Health Organization Classification of Tumors: Pathology and Genetics, Tumours of Lung, Pleura, Thymus and Heart. Lyon: IARC Press; 2004. p. 31-4
|
|
|
|
|
2) Kurahashi N, Inoue M, Liu Y, et al. Passive smoking and lung cancer in Japanese non-smoking women: a prospective study. Int J Cancer. 2008; 122: 653-7
|
|
|
|
|
3) Nitadori J, Inoue M, Iwasaki M, et al. Association between lung cancer incidence and family history of lung cancer: data from a large-scale population-based cohort study, the JPHC study. Chest. 2006; 130: 968-75
|
|
|
|
|
|
4) Hung RJ, Hall J, Brennan P, et al. Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. Am J Epidemiol. 2005; 162: 925-42
|
|
|
|
|
|
5) Kohno T, Kunitoh H, Toyama K, et al. Association of the OGG1-Ser326Cys poly-morphism with lung adenocarcinoma risk. Cancer Sci. 2006; 97: 724-8
|
|
|
|
|
6) Kiyohara C, Otsu A, Shirakawa T, et al. Genetic polymorphisms and lung cancer susceptibility: a review. Lung Cancer. 2002; 37: 241-56
|
|
|
|
|
|
7) Dong LM, Potter JD, White E, et al. Genetic susceptibility to cancer: the role of poly-morphisms in candidate genes. JAMA. 2008; 299: 2423-36
|
|
|
|
|
|
8) Raimondi S, Paracchini V, Autrup H, et al. Meta- and pooled analysis of GSTT1 and lung cancer: a HuGE-GSEC review. Am J Epidemiol. 2006; 164: 1027-42
|
|
|
|
|
|
9) Li H, Hao X, Zhang W, et al. The hOGG1 Ser326Cys polymorphism and lung cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2008; 17: 1739-45
|
|
|
|
|
|
10) Lee KM, Kang D, Clapper ML, et al. CYP1A1, GSTM1, and GSTT1 polymorphisms, smoking, and lung cancer risk in a pooled analysis among Asian populations. Cancer Epidemiol Biomarkers Prev. 2008; 17: 1120-6
|
|
|
|
|
|
11) Amos CI, Wu X, Broderick P, et al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25. 1. Nat Genet. 2008; 40: 616-22
|
|
|
|
|
|
12) Hung RJ, McKay JD, Gaborieau V, et al. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature. 2008; 452: 633-7
|
|
|
|
|
|
13) Thorgeirsson TE, Geller F, Sulem P, et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature. 2008; 452: 638-42
|
|
|
|
|
|
14) Ponder BA. Cancer genetics. Nature. 2001; 411: 336-41
|
|
|
|
|
|
15) Kamataki T, Fujieda M, Kiyotani K, et al. Genetic polymorphism of CYP2A6 as one of the potential determinants of tobacco-related cancer risk. Biochem Biophys Res Commun. 2005; 338: 306-10
|
|
|
|
|
|
16) Raimondi S, Boffetta P, Anttila S, et al. Metabolic gene polymorphisms and lung cancer risk in non-smokers. An update of the GSEC study. Mutat Res. 2005; 592: 45-57
|
|
|
|
|
|
17) Wei Q, Cheng L, Hong WK, et al. Reduced DNA repair capacity in lung cancer patients. Cancer Res. 1996; 56: 4103-7
|
|
|
|
|
|
18) Gorlova OY, Weng SE, Zhang Y, et al. DNA repair capacity and lung cancer risk in never smokers. Cancer Epidemiol Biomarkers Prev. 2008; 17: 1322-8
|
|
|
|
|
|
19) Kohno T, Sakiyama T, Kunitoh T, et al. Association of polymorphisms in the MTH1 gene with small cell lung carcinoma risk. Carcinogenesis. 2006; 27: 2448-54
|
|
|
|
|
|
20) Wilkening S, Bermejo JL, Hemminki K. MDM2 SNP309 and cancer risk: a combined analysis. Carcinogenesis. 2007; 28: 2262-7
|
|
|
|
|
|
21) Sakiyama T, Kohno T, Mimaki S, et al. Association of amino acid substitution poly-morphisms in DNA repair genes TP53, POLI, REV1 and LIG4 with lung cancer risk. Int J Cancer. 2005; 114: 730-7
|
|
|
|
|
|
22) Zienolddiny S, Campa D, Lind H, et al. Poly-morphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis. 2006; 27: 560-7
|
|
|
|
|
|
23) Michiels S, Danoy P, Dessen P, et al. Poly-morphism discovery in 62 DNA repair genes and haplotype associations with risks for lung and head and neck cancers. Carcinogenesis. 2007; 28: 1731-9
|
|
|
|
|
|
24) Schafer M, Werner S. Cancer as an overhealing wound: an old hypothesis revisited. Nat Rev Mol Cell Biol. 2008; 9: 628-38
|
|
|
|
|
|
25) Wu X, Lin J, Etzel CJ, et al. Interplay between mutagen sensitivity and epidemiological factors in modulating lung cancer risk. Int J Cancer. 2007; 120: 2687-95
|
|
|
|
|
|
26) Engels EA, Wu X, Gu J, et al. Systematic evaluation of genetic variants in the inflammation pathway and risk of lung cancer. Cancer Res. 2007; 67: 6520-7
|
|
|
|
|
|
27) Sun T, Gao Y, Tan W, et al. A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers. Nat Genet. 2007; 39: 605-13
|
|
|
|
|
|
28) Kohno T, Kunitoh H, Suzuki K, et al. Association of KRAS polymorphisms with risk for lung adenocarcinoma accompanied by atypical adenomatous hyperplasias. Carcinogenesis. 2008; 29: 957-63
|
|
|
|
|
|
29) Zhang X, Miao X, Liang G, et al. Polymorphisms in DNA base excision repair genes ADPRT and XRCC1 and risk of lung cancer. Cancer Res. 2005; 65: 722-6
|
|
|
|
|
|
30) Larsen JE, Colosimo ML, Yang IA, et al. CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung. Carcinogenesis. 2006; 27: 525-32
|
|
|
|
|
|
31) Zhang X, Miao X, Guo Y, et al. Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with suscep-tibility to lung cancer. Hum Mutat. 2006; 27: 110-7
|
|
|
|
|
|
32) Vineis P, Anttila S, Benhamou S, et al. Evidence of gene gene interactions in lung carcinogenesis in a large pooled analysis. Carcinogenesis. 2007; 28: 1902-5
|
|
|
|
|
|
33) Shiraishi K, Kohno T, Kunitoh H, et al. Contri-bution of nicotine acetylcholine receptor poly-morphisms to lung cancer risk in a smoking-inde-pendent manner in the Japanese. Carcinogenesis; in press
|
|
|
|
|